title: β-Adrenergic blockade for anthracycline- and trastuzumab-induced cardiotoxicity: is prevention better than cure?
authors.forename: Anju
authors.initials: A
authors.lastname: Nohria
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D018943:Anthracyclines / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000517:prevention & control*; D006801:Humans; D000068878:Trastuzumab
chemical_list: D000319:Adrenergic beta-Antagonists; D018943:Anthracyclines; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D002316:Cardiotonic Agents; D000068878:Trastuzumab
keywords: Editorials; anthracyclines; trastuzumab